NEULANDLABNSEQ4FY26May 12, 2026

Neuland Laboratories Limited

4,361words
0turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
May 12, 2026 To BSE Limited Phiroze Jeejeebhoy Towers, 25th Floor, Dalal Street, Mumbai – 400 001 The National Stock Exchange of India Ltd Exchange Pla
Rs. 397
4FY26 as against 145 days in Q3FY26, mainly on account of decrease in inventory. Capex outflow of Rs. 397 Cr in FY26. 6 Q4FY26 Financial Highlights Total Income (Rs. Cr) EBITDA (Rs. Cr) PAT (Rs. Cr)
40.5%
TDA (Rs. Cr) PAT (Rs. Cr) EPS (Rs.) . 8 5 3 3 . 6 0 0 3 . 1 6 1 5 . 8 7 4 4 . 7 8 8 7 40.5% 30.4% 19.0% 17.3% 14.4% . 2 8 5 . 1 2 4 . 9 6 5 1 . 0 5 8 . 4 9 1 3 45.0% 40.0% 35
30.4%
s. Cr) PAT (Rs. Cr) EPS (Rs.) . 8 5 3 3 . 6 0 0 3 . 1 6 1 5 . 8 7 4 4 . 7 8 8 7 40.5% 30.4% 19.0% 17.3% 14.4% . 2 8 5 . 1 2 4 . 9 6 5 1 . 0 5 8 . 4 9 1 3 45.0% 40.0% 35.0% 30
19.0%
PAT (Rs. Cr) EPS (Rs.) . 8 5 3 3 . 6 0 0 3 . 1 6 1 5 . 8 7 4 4 . 7 8 8 7 40.5% 30.4% 19.0% 17.3% 14.4% . 2 8 5 . 1 2 4 . 9 6 5 1 . 0 5 8 . 4 9 1 3 45.0% 40.0% 35.0% 30.0% 25
17.3%
s. Cr) EPS (Rs.) . 8 5 3 3 . 6 0 0 3 . 1 6 1 5 . 8 7 4 4 . 7 8 8 7 40.5% 30.4% 19.0% 17.3% 14.4% . 2 8 5 . 1 2 4 . 9 6 5 1 . 0 5 8 . 4 9 1 3 45.0% 40.0% 35.0% 30.0% 25.0% 20
14.4%
EPS (Rs.) . 8 5 3 3 . 6 0 0 3 . 1 6 1 5 . 8 7 4 4 . 7 8 8 7 40.5% 30.4% 19.0% 17.3% 14.4% . 2 8 5 . 1 2 4 . 9 6 5 1 . 0 5 8 . 4 9 1 3 45.0% 40.0% 35.0% 30.0% 25.0% 20.0% 15
45.0%
7 8 8 7 40.5% 30.4% 19.0% 17.3% 14.4% . 2 8 5 . 1 2 4 . 9 6 5 1 . 0 5 8 . 4 9 1 3 45.0% 40.0% 35.0% 30.0% 25.0% 20.0% 15.0% 10.0% 5.0% 0.0% 26.9% . 5 2 1 2 18.7% 8.3% 4.6%
40.0%
7 40.5% 30.4% 19.0% 17.3% 14.4% . 2 8 5 . 1 2 4 . 9 6 5 1 . 0 5 8 . 4 9 1 3 45.0% 40.0% 35.0% 30.0% 25.0% 20.0% 15.0% 10.0% 5.0% 0.0% 26.9% . 5 2 1 2 18.7% 8.3% 4.6% . 7 7
35.0%
5% 30.4% 19.0% 17.3% 14.4% . 2 8 5 . 1 2 4 . 9 6 5 1 . 0 5 8 . 4 9 1 3 45.0% 40.0% 35.0% 30.0% 25.0% 20.0% 15.0% 10.0% 5.0% 0.0% 26.9% . 5 2 1 2 18.7% 8.3% 4.6% . 7 7 2 . 7
30.0%
4% 19.0% 17.3% 14.4% . 2 8 5 . 1 2 4 . 9 6 5 1 . 0 5 8 . 4 9 1 3 45.0% 40.0% 35.0% 30.0% 25.0% 20.0% 15.0% 10.0% 5.0% 0.0% 26.9% . 5 2 1 2 18.7% 8.3% 4.6% . 7 7 2 . 7 3 1 .
25.0%
0% 17.3% 14.4% . 2 8 5 . 1 2 4 . 9 6 5 1 . 0 5 8 . 4 9 1 3 45.0% 40.0% 35.0% 30.0% 25.0% 20.0% 15.0% 10.0% 5.0% 0.0% 26.9% . 5 2 1 2 18.7% 8.3% 4.6% . 7 7 2 . 7 3 1 . 5 6 9
← All transcriptsNEULANDLAB stock page →